COMPOSITIONS AND METHODS FOR LEACH EXTRACTION OF MICROORGANISMS

IPC classification:

C12P 7/00

Agent:

William Gerrit Arends, Marks & Clerk LLP

Agent:

Dayle Anne Callaghan, Rouse IP Limited

Status:

█ EXAMINATION REQUESTED

ROBOTIC SURGICAL DEVICES, SYSTEMS AND RELATED METHODS

IPC classification:

G05B 15/00, G05B 19/00

Applicant:

The Board of Regents of the University of Nebraska

Agent:

David Michael Grant, Marks & Clerk LLP

Agent:

Boult Wade Tennant Ltd

Agent:

Dayle Anne Callaghan, Rouse IP Limited

Status:

█ GRANT OF PATENT INTENDED

METHOD OF EXTRACTING LUTEIN/XANTHOPHYLLS FROM NATURAL MATERIALS AND HIGHLY PURIFIED LUTEIN/XANTHOPHYLLS OBTAINED FROM THE METHOD THEREOF

IPC classification:

C07C 403/24

Applicant:

Chulalongkorn University

Agent:

Cabinet Plasseraud

Agent:

Dayle Anne Callaghan, Rouse IP Limited

Status:

█ EXAMINATION IN PROGRESS

FUS1/TUSC2 THERAPIES

IPC classification:

A61K 48/00, G01N 33/00

Applicant:

The Board of Regents of the University of Texas System

Agent:

David Michael Grant, Marks & Clerk LLP

Agent:

Boult Wade Tennant Ltd

Agent:

Dayle Anne Callaghan, Rouse IP Limited

Status:

█ PATENT GRANTED

SELF-LAUNCHING MOVABLE SCAFFOLDING SYSTEM

IPC classification:

E01D 21/00

Agent:

Cabinet Plasseraud

Agent:

Dayle Anne Callaghan, Rouse IP Limited

Status:

█ GRANT OF PATENT INTENDED

Improved neurturin molecules

IPC classification:

A61K 38/17, A61P 25/00, C07K 14/47, C07K 14/475

Agent:

David Michael Grant, Marks & Clerk LLP

Agent:

Boult Wade Tennant Ltd

Agent:

Dayle Anne Callaghan, Rouse IP Limited

Status:

█ PATENT GRANTED

Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same

IPC classification:

A61K 9/107, A61K 9/48, A61K 31/568, A61K 47/12, A61K 47/14, A61K 47/44

Agent:

David Michael Grant, Marks & Clerk LLP

Agent:

Boult Wade Tennant Ltd

Agent:

Dayle Anne Callaghan, Rouse IP Limited

Status:

█ GRANT OF PATENT INTENDED

SEPARATOME-BASED PROTEIN EXPRESSION AND PURIFICATION PLATFORM

IPC classification:

C12N 1/20, C12N 15/70, C12N 15/74, C12N 15/79, C12P 21/02

Applicant:

University of Pittsburgh of the Commonwealth System of Higher Education

Applicant:

The Board of Trustees of The University of Arkansas

Agent:

Marks & Clerk LLP

Agent:

Multiple attorneys, Kilburn & Strode LLP

Agent:

Multiple attorneys, Rouse IP Limited

Status:

█ EXAMINATION IN PROGRESS

SYSTEMS AND METHODS TO DETERMINE AND MONITOR CHANGES IN RAIL CONDITIONS

IPC classification:

G01N 29/00

Applicant:

The Board of Regents of the University of Nebraska

Agent:

David Michael Grant, Marks & Clerk LLP

Agent:

Boult Wade Tennant Ltd

Agent:

Dayle Anne Callaghan, Rouse IP Limited

Status:

█ APPLICATION DEEMED TO BE WITHDRAWN

HIGH THROUGHPUT SEQUENCING OF MULTIPLE TRANSCRIPTS OF A SINGLE CELL

IPC classification:

C12Q 1/68

Applicant:

The Board of Regents of the University of Texas System

Agent:

David Michael Grant, Marks & Clerk LLP

Agent:

Boult Wade Tennant Ltd

Agent:

Dayle Anne Callaghan, Rouse IP Limited

Status:

█ GRANT OF PATENT INTENDED

LOCAL CONTROL ROBOTIC SURGICAL DEVICES AND RELATED METHODS

IPC classification:

B25J 9/04, B25J 9/18, B25J 17/02

Applicant:

The Board of Regents of the University of Nebraska

Agent:

David Michael Grant, Marks & Clerk LLP

Agent:

Boult Wade Tennant Ltd

Agent:

Dayle Anne Callaghan, Rouse IP Limited

Status:

█ PATENT GRANTED

APPARATUS FOR CONVERTING ENERGY FROM FLUID FLOW

IPC classification:

F03B 13/08

Agent:

Multiple attorneys, Kilburn & Strode LLP

Agent:

Dayle Anne Callaghan, Rouse IP Limited

Status:

█ EXAMINATION IN PROGRESS

METHODS, SYSTEMS, AND DEVICES RELATING TO OPEN MICROFLUIDIC CHANNELS

IPC classification:

B81B 1/00, B81C 1/00

Agent:

David Michael Grant, Marks & Clerk LLP

Agent:

Boult Wade Tennant Ltd

Agent:

Dayle Anne Callaghan, Rouse IP Limited

Status:

█ GRANT OF PATENT INTENDED

DIRECTIONAL ELUTING IMPLANTABLE MEDICAL DEVICE

IPC classification:

A61F 2/82, A61F 2/86, A61F 2/90

Applicant:

South Dakota Board of Regents

Agent:

David Michael Grant, Marks & Clerk LLP

Agent:

Boult Wade Tennant Ltd

Agent:

Dayle Anne Callaghan, Rouse IP Limited

Status:

█ APPLICATION DEEMED TO BE WITHDRAWN

ASCORBIC ACID-ELUTING IMPLANTABLE MEDICAL DEVICES, SYSTEMS, AND RELATED METHODS

IPC classification:

A61F 2/02

Applicant:

South Dakota Board of Regents

Agent:

David Michael Grant, Marks & Clerk LLP

Agent:

Boult Wade Tennant Ltd

Agent:

Dayle Anne Callaghan, Rouse IP Limited

Status:

█ GRANT OF PATENT INTENDED

ROBOTIC SURGICAL DEVICES, SYSTEMS, AND RELATED METHODS

IPC classification:

A61B 1/313

Applicant:

The Board of Regents of the University of Nebraska

Agent:

David Michael Grant, Marks & Clerk LLP

Agent:

Boult Wade Tennant Ltd

Agent:

Dayle Anne Callaghan, Rouse IP Limited

Status:

█ GRANT OF PATENT INTENDED

A NOVEL TOXIN IN TYPE A CLOSTRIDIUM PERFRINGENS

IPC classification:

A61K 39/08, A61K 39/385, A61P 31/04, A61P 37/04, C07K 14/33, C07K 16/12, C07K 19/00, C12N 15/31, G01N 33/569

Applicant:

University of Guelph

Agent:

William Gerrit Arends, Marks & Clerk LLP

Agent:

Dayle Anne Callaghan, Rouse IP Limited

Status:

█ GRANT OF PATENT INTENDED

GOLD RECOVERY FROM REFRACTORY ORES AND CONCENTRATES

IPC classification:

C22B 3/00, C22B 11/00

Agent:

Marks & Clerk LLP

Agent:

Boult Wade Tennant Ltd

Agent:

Dayle Anne Callaghan, Rouse IP Limited

Status:

█ GRANT OF PATENT INTENDED

METHODS AND SYSTEMS FOR HANDLING OR DELIVERING MATERIALS FOR NATURAL ORIFICE SURGERY

IPC classification:

A61B 1/018

Applicant:

The Board of Regents of the University of Nebraska

Agent:

Dayle Anne Callaghan, Rouse IP Limited

Status:

█ APPLICATION DEEMED TO BE WITHDRAWN

ALPHA-SYNUCLEIN ANTIBODIES AND USES THEREOF

IPC classification:

A61K 39/395, A61P 25/00, C07K 16/44

Applicant:

United Arab Emirates University

Agent:

David Michael Grant, Marks & Clerk LLP

Agent:

Dayle Anne Callaghan, Kilburn & Strode LLP

Status:

█ EXAMINATION REQUESTED

SOFT TISSUE IMPLANT

IPC classification:

A01N 63/00, A61K 35/52, C12N 5/071

Agent:

Dayle Anne Callaghan, Kilburn & Strode LLP

Status:

█ GRANT OF PATENT INTENDED

APPARATUS FOR HANGING DROP DETECTION OF EPIDURAL SPACE PENETRATION

IPC classification:

A61M 5/00

Agent:

Dayle Anne Callaghan, Kilburn & Strode LLP

Status:

█ GRANT OF PATENT INTENDED

VESICLES

IPC classification:

A61K 8/02, A61K 8/06, A61K 8/14, A61K 8/55, A61K 8/67, A61K 9/00, A61K 9/107, A61K 9/127, A61K 47/24, A61K 47/48, A61Q 17/04, A61Q 19/08

Agent:

Dayle Anne Callaghan, Kilburn & Strode LLP

Status:

█ GRANT OF PATENT INTENDED

E. COLI SEPARATOME-BASED PROTEIN EXPRESSION AND PURIFICATION PLATFORM

IPC classification:

C12N 1/20, C12N 15/70, C12N 15/74, C12N 15/79, C12P 21/02

Applicant:

The Board of Trustees of The University of Arkansas

Agent:

Dayle Anne Callaghan, Kilburn & Strode LLP

Status:

█ GRANT OF PATENT INTENDED

MONOVALENT ANTIGEN BINDING CONSTRUCTS TARGETING EGFR AND/OR HER2 AND USES THEREOF

IPC classification:

A61K 39/00, C12N 5/07, C12P 21/06, C12P 21/08

Applicant:

Zymeworks Inc

Agent:

Dayle Anne Callaghan, Kilburn & Strode LLP

Status:

█ EXAMINATION REQUESTED

USE OF FLUORINATED CYCLIC DINUCLEOTIDES AS ORAL VACCINE ADJUVANTS

IPC classification:

A61K 31/7084, A61K 39/39, A61P 31/04, A61P 37/04

Applicant:

National Research Council of Canada

Applicant:

Brock University

Agent:

Dayle Anne Callaghan, Kilburn & Strode LLP

Status:

█ EXAMINATION REQUESTED

FORMULATIONS FOR LYSOSOMAL ENZYMES

IPC classification:

A61K 38/16, A61K 38/17, A61K 38/46, A61K 47/30, A61K 47/34, A61P 3/00

Agent:

Dayle Anne Callaghan, Kilburn & Strode LLP

Status:

█ EXAMINATION REQUESTED

SYNERGISTIC BACTERIAL COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOF

IPC classification:

A61K 35/00, A61K 35/742, A61K 35/744, A61K 35/745

Agent:

Dayle Anne Callaghan, Kilburn & Strode LLP

Status:

█ EXAMINATION IN PROGRESS

BISPECIFIC ANTIGEN-BINDING CONSTRUCTS TARGETING HER2

IPC classification:

A61K 39/395, A61K 47/48, A61P 35/00, C07K 16/28, C07K 16/46, C12N 5/10, C12N 15/13, C40B 40/08

Applicant:

Zymeworks Inc

Agent:

Dayle Anne Callaghan, Kilburn & Strode LLP

Status:

█ EXAMINATION REQUESTED

CANCER TREATMENT WITH COMBINATION OF PLINABULIN AND TAXANE

IPC classification:

A61K 31/337, A61K 31/496, A61P 35/00

Agent:

Dayle Anne Callaghan, Kilburn & Strode LLP

Status:

█ EXAMINATION REQUESTED

NOVEL FULL SPECTRUM ANTI-DENGUE ANTIBODY

IPC classification:

A61K 39/395, A61K 39/42, C07K 16/00, C12P 21/08

Applicant:

Massachusetts Institute of Technology (MIT) Inc.

Agent:

Dayle Anne Callaghan, Kilburn & Strode LLP

Status:

█ EXAMINATION REQUESTED

CARBOXY-CYCLOPROPYL UNDECANOL COMPOUNDS FOR TREATMENT OF LIVER DISEASE AND OTHER MEDICAL DISORDERS

IPC classification:

A61K 31/194, A61P 1/16, A61P 31/12, A61P 31/18

Agent:

Dayle Anne Callaghan, Kilburn & Strode LLP

Status:

█ EXAMINATION REQUESTED

TURBINE ASSEMBLY

IPC classification:

F03B 13/08, F03B 17/06

Agent:

Dayle Anne Callaghan, Kilburn & Strode LLP

Status:

█ EXAMINATION REQUESTED

COMPOSITIONS FOR INFUSION OF TRANSIENTLY ENGRAFTING, SELECTED POPULATIONS OF ALLOGENEIC LYMPHOCYTES

IPC classification:

A61K 38/00, A61P 7/00, A61P 35/00, C12N 5/078

Applicant:

Johns Hopkins University

Agent:

Dayle Anne Callaghan, Kilburn & Strode LLP

Status:

█ EXAMINATION REQUESTED

DEIMMUNIZED LYSOSTAPHIN AND METHODS OF USE

IPC classification:

A61K 38/48, A61P 31/04, C12N 9/52

Agent:

Dayle Anne Callaghan, Kilburn & Strode LLP

Status:

█ EXAMINATION REQUESTED

MODIFIED LATENCY ASSOCIATED PROTEIN CONSTRUCT

IPC classification:

C07K 14/495, C12N 15/62

Agent:

Dayle Anne Callaghan, Kilburn & Strode LLP

Status:

█ EXAMINATION REQUESTED